Concepedia

David Loch

DL

Statistics

Publications

13

Citations

1.2K

H-Index

12

Active since

2002

Affiliations

The University of Queensland(Current)

University of Southern Queensland

Johns Hopkins University

Queensland University of Technology

Howard Hughes Medical Institute

David Loch is an author at The University of Queensland specializing in medicine, cardiology, and pharmacology.

Publications per year

2002–2013

13

Publications

13

Circulating Transforming Growth Factor-β in Marfan Syndrome

Peter Matt, Florian Schoenhoff, Jennifer Habashi et al. · Circulation · 2009 · 270 citations · Full text

, , +14

Angiotensin II–dependent TGF-β signaling contributes to Loeys-Dietz syndrome vascular pathogenesis

Elena Gallo, David Loch, Jennifer Habashi et al. · Journal of Clinical Investigation · 2013 · 250 citations

, , +14

The N550K/H Mutations in FGFR2 Confer Differential Resistance to PD173074, Dovitinib, and Ponatinib ATP-Competitive Inhibitors

Sara A. Byron, Huaibin Chen, Andreas Wortmann et al. · Neoplasia · 2013 · 136 citations · Full text

, , +16

p38 MAPK Is an Early Determinant of Promiscuous Smad2/3 Signaling in the Aortas of Fibrillin-1 (Fbn1)-null Mice

Luca Carta, Silvia Smaldone, Lior Zilberberg et al. · Journal of Biological Chemistry · 2008 · 102 citations · Full text

, , +14

Prevention of hypertension in DOCA-salt rats by an inhibitor of soluble expoxide hydrolase

David Loch, Andrew Hoey, Christophe Morisseau et al. · Cell Biochemistry and Biophysics · 2007 · 87 citations · Full text

, , +14

1–5 of 13